
Exosome Research Products Market by Product & Service (Instruments, Kits & Reagents, Services), Application (Cancer Applications, Non-Cancer Applications), End User - Global Forecast 2023-2030
Description
Exosome Research Products Market by Product & Service (Instruments, Kits & Reagents, Services), Application (Cancer Applications, Non-Cancer Applications), End User - Global Forecast 2023-2030
The Exosome Research Products Market size was estimated at USD 145.31 million in 2022 and expected to reach USD 162.90 million in 2023, at a CAGR 12.24% to reach USD 366.05 million by 2030 .
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Exosome Research Products Market.
- Based on Product & Service, market is studied across Instruments, Kits & Reagents, and Services. The Services is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Cancer Applications and Non-Cancer Applications. The Cancer Applications is further studied across Breast Cancer, Colorectal Cancer, Lung Cancer, and Prostate Cancer. The Non-Cancer Applications is projected to witness significant market share during forecast period.
- Based on End User, market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies. The Hospitals & Clinical Testing Laboratories is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Exosome Research Products Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Exosome Research Products Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Exosome Research Products Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, BioCat GmbH, Fujifilm Holdings Corporation, HiSS Diagnostics GmbH, Lonza Group Ltd., Malvern Panalytical Ltd., MBL International Corporation, Miltenyi Biotec B.V. & Co. KG, NanoSomiX, Inc., Norgen Biotek Corp., Nx Pharmagen Inc., System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Exosome Research Products Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Exosome Research Products Market?
- What is the competitive strategic window for identifying opportunities in the Exosome Research Products Market?
- What are the latest technology trends and regulatory frameworks in the Exosome Research Products Market?
- What is the market share of the leading vendors in the Exosome Research Products Market?
- Which modes and strategic moves are suitable for entering the Exosome Research Products Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Exosome Research Products Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand with prevalence of cancer
- 5.1.1.2. Rising interest for exosome-based procedures
- 5.1.1.3. Increasing funding for life science research
- 5.1.2. Restraints
- 5.1.2.1. Dearth of skilled and trained professional
- 5.1.3. Opportunities
- 5.1.3.1. Emerging demand from pharmaceutical and biotechnology companies
- 5.1.3.2. Rising preference for personalized medicine and targeted treatment
- 5.1.4. Challenges
- 5.1.4.1. Reduced awareness on benefits of exosome research product
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Exosome Research Products Market, by Product & Service
- 6.1. Introduction
- 6.2. Instruments
- 6.3. Kits & Reagents
- 6.4. Services
- 7. Exosome Research Products Market, by Application
- 7.1. Introduction
- 7.2. Cancer Applications
- 7.3.1. Breast Cancer
- 7.3.2. Colorectal Cancer
- 7.3.3. Lung Cancer
- 7.3.4. Prostate Cancer
- 7.3. Non-Cancer Applications
- 8. Exosome Research Products Market, by End User
- 8.1. Introduction
- 8.2. Academic & Research Institutes
- 8.3. Hospitals & Clinical Testing Laboratories
- 8.4. Pharmaceutical & Biotechnology Companies
- 9. Americas Exosome Research Products Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Exosome Research Products Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Exosome Research Products Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AMS Biotechnology (Europe) Limited
- 13.1.2. BioCat GmbH
- 13.1.3. Fujifilm Holdings Corporation
- 13.1.4. HiSS Diagnostics GmbH
- 13.1.5. Lonza Group Ltd.
- 13.1.6. Malvern Panalytical Ltd.
- 13.1.7. MBL International Corporation
- 13.1.8. Miltenyi Biotec B.V. & Co. KG
- 13.1.9. NanoSomiX, Inc.
- 13.1.10. Norgen Biotek Corp.
- 13.1.11. Nx Pharmagen Inc.
- 13.1.12. System Biosciences, LLC
- 13.1.13. Takara Bio Inc.
- 13.1.14. Thermo Fisher Scientific Inc.
- 13.1.15. ZenBio, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.